Mobidays Inc. (KOSDAQ:363260)
1,657.00
+16.00 (0.98%)
At close: Aug 7, 2025, 3:30 PM KST
Ligand Pharmaceuticals Revenue
Mobidays had revenue of 11.11B KRW in the quarter ending March 31, 2025, with 64.36% growth. This brings the company's revenue in the last twelve months to 41.58B, up 55.57% year-over-year. In the year 2024, Mobidays had annual revenue of 37.23B with 55.85% growth.
Revenue (ttm)
41.58B
Revenue Growth
+55.57%
P/S Ratio
1.25
Revenue / Employee
361.59M
Employees
115
Market Cap
52.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.23B | 13.34B | 55.85% |
Dec 31, 2023 | 23.89B | 7.84B | 48.85% |
Dec 31, 2022 | 16.05B | -2.63B | -14.10% |
Dec 31, 2021 | 18.69B | 4.04B | 27.62% |
Dec 31, 2020 | 14.64B | -8.43B | -36.54% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
Doosan Enerbility | 15.88T |
HD Hyundai Heavy Industries | 15.32T |